Morgan Stanley Meridian Bioscience Inc Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $1.56 Million - $1.67 Million	50,062 Added 8.41%	645,066 $21.4 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $6 Million - $6.51 Million	194,099 Added 48.42%	595,004 $18.8 Million
Q2 2022 Oct 27, 2022	BUY	$23.75 - $31.69 $3.32 Million - $4.43 Million	139,786 Added 53.53%	400,905 $12.2 Million
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $3.32 Million - $4.43 Million	139,786 Added 53.53%	400,905 $12.2 Million
Q1 2022 Oct 27, 2022	SELL	$19.97 - $26.94 $2.79 Million - $3.77 Million	-139,786 Reduced 34.87%	261,119 $6.78 Million
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $1.08 Million - $1.46 Million	-54,164 Reduced 17.18%	261,119 $6.78 Million
Q4 2021 Feb 14, 2022	BUY	$17.46 - $21.61 $2.08 Million - $2.57 Million	119,082 Added 60.69%	315,283 $6.43 Million
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $3.4 Million - $4.41 Million	196,201 New	196,201 $3.78 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.